Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02843945 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT02843945 · ClinicalTrials.gov record · last posted 2025-06-17

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Name: Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source — clinical trial record (NCT02843945)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1/2

SponsorCivaTech Oncology

Started2017-05-31

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

Initial study to evaluate local control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor removal.

Amendment record 10 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 10 times since 2016-07-21; most recent amendment 2025-06-16. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2017-08-17

Status change Not Yet Recruiting→Recruitingv1

Trial Details

NCT Number	NCT02843945
Lead Sponsor	CivaTech Oncology
Conditions	Pancreatic Cancer
Enrollment	80 participants
Start Date	2017-05-31
Primary Completion	2027-10-29 (estimated)
Study Completion	2028-10-30 (estimated)
Updated on ClinicalTrials.gov	2025-06-17